Search

everythinglearnresearchcommunity

for

Search:↓

A 20-year-old woman had stable Progressive Hemifacial Atrophy and Vitiligo after treatment, suggesting a possible link between the conditions.

A rare scalp condition can occur due to leukemia affecting the skin.

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

Lupus and frontal fibrosing alopecia may share a common cause.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

The letter suggests that the study's comparison group might have affected the results and calls for larger, more detailed future research.

The Italian guidelines offer advice for diagnosing and treating alopecia areata based on expert opinion and limited clinical trial evidence.

More research is needed to understand and manage angioedema in pregnant women with lupus.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Young men with early hair loss and high SAA3 levels are at higher risk for heart disease.

A man's scalp condition was misidentified as hair loss dots but was actually a common follicular disorder.

SLE should be considered when investigating the cause of a stroke to prevent more strokes.

Hair loss may indicate higher risk of heart disease.

Clonally expanded CD8+ T cells cause alopecia areata.

People with alopecia areata may have a higher risk of blood clots.

Non-itchy rashes can indicate serious diseases like lupus.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.

CCCA causes progressive hair loss in Black women, starting from a central scalp patch.

Early recognition and treatment of VATS in transplant patients improve outcomes.

Reducing immunosuppression and using antiviral creams improved the woman's skin condition.

Alopecia areata causes unpredictable hair loss and requires personalized treatment.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Asthma may increase the risk of alopecia areata.

Early diagnosis and treatment with corticosteroids can improve outcomes in Cronkhite–Canada syndrome.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Alopecia areata involves immune response and gene changes affecting hair loss.

Vogt-Koyanagi syndrome often leads to partial or complete blindness and responds poorly to treatment.

Skin problems are common and early signs of Systemic Lupus Erythematosus, and certain immune system markers are important for diagnosis and treatment.